US2008108052A1PendingUtilityA1
Use of Ribozymes in the Detection of Adventitious Agents
Est. expiryFeb 28, 2022(expired)· nominal 20-yr term from priority
Inventors:Matthew C. Coffey
C12Q 2521/337C12N 15/1131C12Q 1/04C12Q 1/701C12N 2310/121
69
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention provides a method of detecting adventitious agents in a composition comprising a microorganism by using ribozyme-expressing indicator cells, as well as indicator cells useful in such detection.
Claims
exact text as granted — not AI-modified1 - 31 . (canceled)
32 . A method of detecting the presence of an adventitious agent in a therapeutic composition comprising a reovirus, the method comprising the steps of:
(a) providing a population of indicator cells that expresses a ribozyme, wherein the ribozyme is capable of specifically cleaving the genome of the reovirus; (b) contacting the indicator cells with the therapeutic composition comprising a reovirus under conditions that allow for cleavage of the genome of the reovirus by the ribozyme; and (c) detecting the presence or absence of a pathogenic effect on the indicator cells contacted with the therapeutic composition, wherein the presence of a pathogenic effect indicates the presence of an adventitious agent in the therapeutic composition.
33 . The method of claim 1 wherein the indicator cells express the ribozyme from a gene that is integrated into the genome of the cells.
34 . The method of claim 1 wherein the ribozyme is capable of specifically cleaving the sl RNA of the reovirus.
35 . The method of claim 1 wherein the ribozyme is Rz-553 or Rz-984.
36 . The method of claim 1 wherein the reovirus is a mammalian reovirus or a human reovirus.
37 . The method of claim 1 wherein the reovirus is a serotype 3 reovirus.
38 . The method of claim 1 wherein the reovirus is a recombinant reovirus.
39 . The method of claim 1 , wherein the population of indicator cells comprises human cells.
40 . The method of claim 1 , wherein the adventitious agent is an infectious agent, other than reovirus, which is capable of infecting the indicator cell.Join the waitlist — get patent alerts
Track US2008108052A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.